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ABSTRACT
Objective: Bauhinia phoenicea Wight and Arn. is a medicinal plant endemic to Southern Western Ghats. In the traditional systems of medicine, it is 
using against various ailments including some oxidative disorders. Detailed studies on the pharmacological activities of this plant are not yet reported. 
Hence, this paper aimed to prove the efficacy of this plant as a natural antioxidant source.
Methods: The sequential extracts of the dried leaf powder were assayed for an antioxidant property using 2,2 diphenyl 1-picrylhydrazyl free radical 
scavenging assay, in vitro cytotoxicity of the extracts was screened using Trypan blue exclusion method. The antitumor activity of the selected fractions 
was studied using ascites tumor affected mice and noted the percentage of increase in lifespan.
Results: The free radical scavenging activity of all extracts was increasing with increasing concentration of the drug, the least IC50 value was showed 
by ethanol fraction (41 µg/ml). The plant drug was not toxic to the normal cells and was highly toxic to tumor cell lines. Maximum in vitro cytotoxicity 
was observed in chloroform fraction (98% cell death at 100 mg/ml) and the least IC50 value was exhibited by the aqueous fraction (34 mg/ml). Both 
the aqueous and chloroform fractions increased the lifespan of ascites tumor bearing mice, aqueous fraction in 100 mg/ml concentration shows 
71.9% increase in lifespan which is near to the result showed by the commercial anticancer drug cyclophosphamide (72.5%). 
Conclusion: According to our results, it is concluded that leaf of B. phoenicea has significant antioxidant, cytotoxic, and antitumor properties 
supporting the folk medicinal use of this species. The further procedures of identification of pharmacological active principles are in progress.
Keywords: Bauhinia phoenicea, Antioxidant property, Cytotoxicity, Antitumor property.
INTRODUCTION
Cancer is potentially fatal disease mainly caused by environmental 
factors which mutate genes coding critical cell regulating proteins. It 
causes 1 in 8 deaths all over the world and rapidly becoming a global 
pandemic. The aberrant cell resulted in causes dissemination of the 
disease and finally leads to patient death by behaving abnormally and 
destroys surrounding normal tissues [1]. Production of free radicals in 
the body beyond its antioxidant capacity has been related to a number 
of oxidative stress diseases including cancer [2]. Diets with plenty of 
fruits and vegetables are protective against oxidative stress-related 
diseases. It is linked to the presence of antioxidant principles which 
are responsible for much of their flavor and color [3].The present-day 
cancer treatments include chemotherapy and radiation therapy which 
causes several deleterious side effects. Therefore, natural therapeutics 
with less or no toxicity is an emerging field of research nowadays.
Bauhinia phoenicea belongs to the family Caesalpiniaceae is a liana 
found in evergreen forests. It is endemic to the Western Ghats. In the 
traditional systems of medicine, it is using against various ailments 
including some oxidative disorders [4]. Many species of Bauhinia 
have demonstrated antidiabetic activity [5-7]. Leaves and Bark of 
this plant have proved antimicrobial, antioxidant, and anthelmintic 
properties [8,9].
In our search for new natural sources of antioxidant agents, we have 
conducted an antioxidant activity screening of some traditionally 
important medicinal plants [8-11], from which the most active 
B. phoenicea was selected for detailed study. To the best of our 
knowledge, no detailed study on the pharmacological activity of this 
plant has been carried out.
METHODS
Collection of plant sample
Fresh leaves of B. phoenicea were collected from the Botanical garden 
St. Mary’s College, Thrissur, Kerala, India, which are the identified plant 
given from MS Swaminathan Research Foundation Wayanad, Kerala, 
India, and submitted a voucher specimen in our department herbarium. 
The plant name checked with www.theplantlist.org.
Preparation of plant extract
The leaves were dried at 45–50°C for 2 weeks and powdered using 
mixer grinder. Dried powder was then extracted sequentially with 
petroleum ether, benzene, chloroform, acetone, ethanol, and distilled 
water using column chromatography. The extracts were concentrated 
to dryness using a rotary evaporator, and the extractive values were 
determined.
Cell lines
Dalton’s lymphoma ascites (DLA) cell lines were procured from Amala 
Cancer Research Institute, Thrissur, Kerala, India. The mice were 
injected with a suspension of cells (1×106) intraperitonealy, and the 
cells were aspirated from the peritoneal cavity on the 15th day.
Animals
Swiss Albino mice (non-pregnant females of 6–8 weeks) were purchased 
from Small Animal Breeding station, College of Veterinary and Animal 
Sciences, Mannuthy, Thrissur, Kerala. They were kept in well-aerated 
cages with controlled conditions of light and humidity for 14 days for 
acclimatization. The mice were fed with normal mouse chow (Sai Durga 
Food and Feeds, Bangalore, India) and water ad libitum. All experiments 
in the study were carried out with the prior approval of Institutional 
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Animal Ethics Committee and were conducted as per the guidelines of 
Committee for the Purpose of Control and Supervision of Experiments 
on Animals constituted by the Animal Welfare Division of Government 
of India.
Antioxidant property screening using 2,2 diphenyl 1-picrylhydrazyl 
(DPPH) free radical scavenging assay
The potential of the B. phoenicea to scavenge the free radicals 
generated was screened according to the method described by Braca 
et al. [12].DPPH free radicals give a strong absorption maximum at 
515 nm and are purple in color. As the odd electrons of DPPH paired 
with hydrogen from the antioxidant compound to form the reduced 
compound DPPH-H, the color of the solution turns from purple to 
yellow.
The diluted working solutions of the test extracts (10–200 µg/ml 
concentration) with DPPH solution were kept in the dark for 20 min. 
Methanol (900 µl) with DPPH solution (6.34 µM, 100 µl) was taken as 
control and methanol as blank. The optical density was recorded, and 
percentage of inhibition was calculated using the formula given below:
Percent (%) inhibition of DPPH activity=A−B/A×100
Where, A=Optical density of the control and B=Optical density of the 
sample.
Acute toxicity study
Acute toxicity assay was performed in healthy adult non-pregnant 
female Swiss albino mice (25–28 g b.wt). The mice were divided into two 
groups of three each and treated with 250 mg/kg drug intraperitoneally. 
The control group received 2% carboxymethyl cellulose suspension at 
the same volume.
In vitro cytotoxicity screening
Short-term cytotoxic activity of B. phoenicea extract was assayed by 
determining the percentage of viability of the DLA cells using Trypan 
blue exclusion methods [13].
The cells were aspirated from the peritoneal cavity of tumor bearing 
mice. The collected cells were washed using phosphate buffered 
saline (PBS) and checked for their viability. Different dilutions of 
the cells were made (10−1, 10−2, and 10−3). The number of cells in the 
10−3 dilution was counted using hemocytometer, and the cell number 
was adjusted to 1×107 cells/ml. This cell suspension was added to 
tubes containing various concentrations of the test in 1 ml PBS and 
the tubes are incubated at 37°C for 3 h. 100 µl of Trypan blue was 
added after the incubation period, and the percentage of viability was 
determined.
Determination of the anticancer effect of B. phoenicea on ascites 
tumor bearing animals
Ascites tumor was induced by injecting DLA cells (1×106 cells/animal) 
in the peritoneal cavity of Swiss albino mice. 36 animals get divided into 
six groups; each group consist of 6 animals. Group I was maintained as 
a negative control (not treated with any drug). Group II–V received 50 
and 100 mg/kg b.wt of aqueous and chloroform extracts of B. phoenicea, 
respectively. Animals in the Group VI received cyclophosphamide 
(10 mg/kg b.wt). The drugs were given intraperitoneally 24 h after 
the tumor implantation as 5 doses on alternate days. The death of the 
animals due to tumor burden was noted every day, and the percentage 
of increase in lifespan (% ILS) was calculated using the formula 
(T-C/C)×100, where “T” and “C” are the mean survival days of treated 
and control animals [14].
RESULTS
Extractive values
The yield of the extracts was found to be 3% w/w (petroleum ether), 
5.05% w/w (benzene), 4.5% w/w (chloroform), 6% w/w (ethanol), 
1.08% w/w (acetone), and 16.06% w/w (aqueous).
Antioxidant property screening using DPPH free radical scavenging 
assay
The effect of antioxidants present in the plant extract on DPPH free 
radical scavenging was thought to be due to their hydrogen donating 
ability. The free radical scavenging effect of B. phoenicea increased with 
an increasing concentration of the extract (Fig. 1). The IC50 values of the 
extracts presented in Table 1.
Acute toxicity study
In the toxicity test dose of 250 mg/kg b.wt, the mice did not cause 
mortality or any signs of toxicity or change in general behavior during 
the 14 days of observation.
In vitro cytotoxicity analysis
Both polar and non-polar extracts of B. phoenicea found to be cytotoxic 
toward DLA cells (Fig. 2). Maximum cytotoxicity (98%) was attained 
at a concentration of 200 µg/ml of chloroform extract. Least IC50 value 
was showed by aqueous extract (Table 1) so chloroform and aqueous 
extracts were selected for anticancer screening.
Effect of B. phoenicea extracts on ascites tumor development
Animals of the ascites tumor control group survived only for a period of 
16±2 days. Treatment of B. phoenicea chloroform and aqueous extracts at 
different concentrations increased the survival rate of animals (Table 2).
DISCUSSION
Medicinal plants are nature’s gift to human beings to lead a healthful, 
disease-free life. Most of these plants used today are believed to 
be much safer and proved an elixir in the treatment of various 
ailments. Plant-derived compounds have played an important role 
in the development of several clinical useful anticancer agents [15]. 
Oxidative stress induced by an imbalance between production 
of reactive oxygen species and antioxidants has associated with 
pathogenic disease conditions like carcinogenesis [16].Hence, radical 
Fig. 1: 2,2 diphenyl 1-picrylhydrazyl free radical scavenging assay 
of Bauhinia phoenicea
Fig. 2: In vitro cytotoxicity screening of Bauhinia phoenicea
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scavenging activity is very important, in the searching of natural 
sources of cancer drugs.
Cytotoxicity is one of the chemotherapeutic targets of antitumor drugs.
Most of the clinically proved antitumor agents possess significant 
cytotoxic activity in cell culture systems. The cytotoxic activity of 
B. phoenicea leaf extracts against DLA cell lines partially explains its 
significant antitumor activity. The drug shows toxicity toward the 
tumor cell line and not toxic to normal cells.
The anticancer activity was evaluated using the ascites tumor model. 
Both chloroform and aqueous extracts of B. phoenicea increased the 
lifespan of affected mice effectively. The highest activity was observed 
in aqueous extract.
The result of the DPPH free radical scavenging assay shows the potential 
of B. phoenicea as an antioxidant agent, efficiency in the in vitro 
cytotoxicity screening, and as an antitumor agent proves that it can 
act as a source in the preparation of anticancer drugs. The presence of 
various secondary metabolites [17] provides some scientific evidence 
for the biological activities and also account for the pharmacological 
uses. The present data would certainly help to understand the potency 
of the plant for medicinal use.
CONCLUSION
The results of the present study reveal that such as vinca alkaloids, 
podophyllotoxins, and camptothecins the proved natural compounds 
for cancer treatment B. phoenicea will also contribute to cancer 
treatments in future. Till now, this plant is considering as a disturbance 
for forest plants, our paper first reporting the anti-cancerous property 
of this plant. Further investigations are in progress to identify and 
isolate the active components of this plant.
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Table 1: DPPH free radical scavenging assay and in vitro cytotoxicity screening using Trypan blue exclusion method
Sl No. B. phoenicea extract IC50 value (µg/ml)
DPPH radical scavenging assay In vitro cytotoxicity screening
1. Petroleum ether 57 40
2. Benzene 65 48
3. Chloroform 46 70
4. Ethanol 41 64
5. Acetone 53 85
6. Aqueous extract 46 34
DPPH: 2,2 diphenyl 1-picrylhydrazyl, B. phoenicea: Bauhinia phoenicea
Table 2: Screening of the anticancer efficiency of B. phoenicea using ascites tumor affected mice models
Sl No. Treatment Number of days survived % increase in lifespan
1. DLA cells alone 16±2 -
2. DLA+B. phoenicea chloroform extract (50 mg/kg b.wt) 20.6±1.5 28.75
3. DLA+B. phoenicea chloroform extract (100 mg/kg b.wt) 26.6±2.80 66.25
4. DLA+B. phoenicea aqueous extract (50 mg/kg b.wt) 22.8±2.13 42.5
5. DLA+B. phoenicea aqueous extract (100 mg/kg b.wt) 27.5±2 71.9
6. DLA+Cyclophosphamide (10 mg/kg) 27.6±2 72.5
B. phoenicea: Bauhinia phoenicea, DLA: Dalton’s lymphoma ascites
